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Abstract. Human melanoma cells (M21) actively at- 
tach and spread on a fibronectin substrate. Indirect 
immunofluorescence assays with specific monoclonal 
antibodies directed to the disialoganglioside GD2, the 
major ganglioside expressed on M21 melanoma cells, 
indicate that during the cell attachment process this 
molecule redistributes into microprocesses that make 
direct contact with the fibronectin substrate. Scanning 
and transmission immunoelectron microscopic studies 
with anti-GD2 monoclonal antibodies and immuno- 
gold staining demonstrate that GD2 preferentially lo- 
calizes into substrate-associated microprocesses that 
emanate from the plasma membrane of the M21 cells. 
Staining with monoclonal antibodies directed to other 
melanoma surface antigens fails to demonstrate a sim- 
ilar distribution pattern on these cells. Direct evidence 
is provided that GD2 is involved in M21 cell attach- 
ment to fibronectin, since treatment of these cells with 
anti-GD2 monoclonal antibodies causes cell rounding 
and detachment from a fibronectin substrate. More- 
over, scanning electron microscopy demonstrates that 
this loss of attachment of fibronectin is characterized 
by a perturbation of  the cell attachment-promoting 
microprocesses that in the presence of these antibodies 
lose contact with the fibronectin substrate. 
umber of studies have indicated that the carbohydrate 
moiety of gangliosides plays a  direct  role in  cell- 
substratum  interactions,  thus  implicating  them  as 
putative cell surface receptors for fibronectin and collagen (8, 
18, 29, 49). In a previous paper, we used monoclonal anti- 
bodies (Mabs)  ~  that specifically  recognize carbohydrate deter- 
minants on the gangliosides GD2 and GD32 (8) to localize 
them on the surface of  human melanoma cells and their focal 
adhesion plaques. The contention that gangliosides  are indeed 
important  molecules  in  cell-substratum  interactions  is 
strengthened by the fact that pretreatment of melanoma cells 
with specific  Mabs directed to either GD2 or GD3 significantly 
decreased their ability to attach and spread on a variety of 
extracellular matrix proteins, which include fibronectin, vitro- 
nectin, laminin, and collagen (10). 
The  attachment and  spreading of cells on  extracellular 
matrix components undoubtedly  involve very complex inter- 
actions which include not only specific receptors (1, 4, 5, 13, 
15, 27, 31, 33, 45, 46) on the surface of the membrane but 
also cytoskeletal components beneath it (22, 35, 36). Com- 
ponents of substrate-attached cell adhesion plaques include 
cytoskeletal proteins (22, 35, 36) and proteoglycans (14, 21, 
I. Abbreviations used in this paper: HBSS, Hanks' balanced salt solution; Mabs, 
monoclonal antibodies; SEM, scanning electron microscopy; TEM, transmis- 
sion electron microscopy; TLC, thin layer chromatography. 
2. Gangliosidcs are termed according to the nomenclature of  Svennerholm (43). 
22), as well as gangliosides (8,  26). A chemical analysis of 
such adhesion plaques demonstrated the presence of ~ 1% of 
cell proteins and phospholipid but as much as 5-15 % of  their 
carbohydrate (l 1). Taken together, these results suggest that 
complex carbohydrates, whether on a protein or lipid back- 
bone, may play a role in cell attachment processes. At this 
time, it is unclear whether such glycoconjugates interact in- 
dependently or in a synergistic  manner with various other cell 
surface components to promote the attachment  and spreading 
of  cells. The use of  specific Mabs directed to defined complex 
carbohydrates may make it possible to dissect the specific  role 
of  these molecules in the cell attachment process. We describe 
here experiments designed to investigate the role of the disi- 
aloganglioside GD2 in the attachment and spreading of M21 
human melanoma cells on a fibronectin substrate through the 
use of Mabs directed specifically  to the carbohydrate portion 
of GD2. Using indirect immunofluorescence as well as scan- 
ning and transmission immunoelectron microscopy, we dem- 
onstrate that this molecule specifically  localizes  within micro- 
processes on these cells when they are attached to fibronectin. 
Scanning electron microscopic studies also reveal that when 
M21  cell monolayers  are  overlayed with  anti-GD2,  they 
round-up as the GD2-containing microprocesses lose contact 
with the fibronectin substrate. Gangliosides may therefore be 
among the important glycoconjugates  associated with the cell 
surface that are  involved in the  very complex process of 
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Materials and Methods 
Cell Lines 
The M21 human melanoma cell line was kindly provided by Dr. D. L. Morton 
(University of California, Los Angeles). These cells were propagated at 37°C in 
7.5% CO2/92.5% air in RPMI 1640 media, supplemented with 10% fetal calf 
serum, and were shown to be free of mycoplasma by repeated testing during 
the course of these studies. 
Mabs 
The various sources of Mabs used in these studies are listed with their isotype 
denoted in parentheses. Mabs 126 (IgM) and  14.18 (IgG3)  produced in our 
laboratory (38) and Mab 3F8 (IgG3)  provided by Dr. N. K. Cheung of Case 
Western Reserve School of Medicine (37)  were  shown to be directed to the 
carbohydrate portion ofganghoside GD2. Mab 9.2.27 (IgG2a) produced in our 
laboratory  was shown to  be  directed  to  a  250-kD core glycoprotein of a 
melanoma-associated  chondroitin sulfate proteoglycan (2). All IgG Mabs were 
isolated from murine ascites fluid and purified by using a protein A-Sepharose 
(Pbarmacia Fine Chemicals, Piscataway,  NJ) immunoadsorbent procedure as 
previously described (28). Mab of the IgM isotype was isolated from murine 
ascites as previously described (44). The antibodies directed to GD2 used in this 
study  were shown not to react with carbohydrate  determinants  on glycoproteins. 
Specifically, these Mabs did not immunoprecipitate a protein from metaboli- 
cally labeled melanoma cells,  nor did  they react  by Western immunoblot 
analysis (Fig.  1). Furthermore, M21 human melanoma cells pretreated with 
mild trypsin actually reacted better with these Mabs, yet failed to react with a 
Mab directed to the protein antigen recognized by Mab 9.2.27 (data not shown). 
Purification of  Melanoma-associated Gangliosides, 
and Thin Layer Chromatography (  TLC) 
Ganghosides associated with M2 !  human melanoma cells  were  purified as 
previously described (8). M21  gangliosides (1 #1 packed cell equivalent) were 
resuspended in chloroform/methanol (2:1), spoUed per lane on plastic backed 
sillea gel TLC plates (Merck & Co., Inc., Rahway, NJ), and developed for 2 h 
in  a  solvent  that  contained  chloroform/methanol/0.2%  aqueous  CaCI2 
(55:45:10). The ganglioside standards GM2, GM~, GD3, and GD2 were spotted 
on each chromatogram and either visualized with resorcinol spray reagent as 
described (43) or reacted with anti-GD2 as described below. 
Immunostaining of Gangliosides Separated by TLC 
The reactivity of Mabs 126 and 14.18 with authentic ganglioside standards or 
M21  ganghosides separated by TLC was determined by using an indirect 
immunostaining  ELISA detection system as previously described (9). 
Western Blot Analysis 
Detergent lysates of M21 human melanoma cells were prepared as previously 
described (2). Lysates were eleetrophoresed on 5% polyacrylamid¢ gels in the 
presence of SDS according to the method of Laemmli (23). Electrotransfer of 
the antigen from the polyacrylamide gels to nitrocellulose paper and develop- 
ment of the blots were done according to Towbin et al. (47). Mabs 126, 14.18, 
and 9.2.27 were used as primary antibody in the form of spent culture media, 
and goat anti-mouse antibody conjugated to horseradish peroxidase (Bio-Rad 
Laboratories, Richmond, CA) was used as secondary antibody. 
Indirect Immunofluorescence 
M21 melanoma cells were allowed to attach for 60-90 min to glass coverslips 
previously coated  for 24  h  with human plasma fibroneetin at  5  ~g/ml in 
phosphate-buffered saline, pH 7.2 (PBS). ARer the cells had aRached they were 
fixed with either 3% paraformaldehyde or 0.5% glutaraldehyde for 15 rain at 
room temperature. Each coverslip was then individually washed several times 
in Hanks' balanced salt solution (HBSS) (Gibco, Grand Island, NY), followed 
by an additional wash in HBSS that contained 0.1  M glycine.  The cells were 
then overlayed with an appropriate Mab at a concentration of-5 ~g/ml for l 
h at room temperature. After three washes in HBSS that contained 1% bovine 
serum albumin (BSA), the cells were overlayed with fluorescein isothiocyanate-- 
conjugated goat anti-mouse IgG (Bio-Rad Laboratories) diluted 50-fold  in 
HBSS that contained  1%  BSA  for  l  h  at  room temperature.  After three 
additional washes, the coverslips were inverted and mounted on slides in a drop 
of fluoromount-G (Fischer Scientific,  Springfield,  N  J). The stained cells were 
observed through a  Zeiss epifluorescent microscope and photographed. To 
examine foeal-adhesion plaques, cells  were  removed from the fibronectin- 
coated coverslips with EDTA as previously described (8). 
Scanning and Transmission Electron Microscopy 
M21  cells  were  seeded on  fibronectin-coated glass coverslips (for scanning 
electron microscopy [SEM]) or 35-ram culture dishes (for transmission  electron 
microscopy [TEM])  as described above (in immunofluorescence) and fixed 
using 0.5%  glutaraldehyde in PBS for 30 rain at room temperature. After a 
brief wash in HBSS that contained 0.1  M  glycine,  the appropriately diluted 
routine Mab was added to each coverslip or dish for 3 h to allow penetration 
of substrate-attached zones. After three washes  each sample was overlayed with 
goat anti-mouso IgG  (Cappel  Laboratories,  Cochranvllle,  PA)  coupled to 
colloidal gold (16). Gold was prepared using the ether phosphorus (5-7 nm) or 
the Na-citrate (20-30 nm) reduction of anrochloric acid methods (40). After 
conjugation each preparation was centrifuged to remove aggregates and then 
tested for its ability to specifically stain the IgG band ofimmunoblotted mouse 
serum after separation by polyacrylamide gel electrophoresis (Pytela,  R., and 
F.  G.  Klier,  unpublished observation). After incubation with  gold-labeled 
secondary antibody, the cells were  washed three times and fixed with 2.5% 
glutaraldehyde in PBS, washed, and postfixed in 1% OsO4. For TEM studies 
thiocarbohydrazide-osmium  double fixation was done to increase contrast. For 
SEM,  tannic acid was used to prevent excessive shrinkage as previously de- 
scribed (48).  All samples were  dehydrated using a  graded series of ethanols 
from 50 to 100%. All 35-ram dishes were embedded in EPOn 812 and cured in 
vacuo for 48 h  at 60°C (19)  and sectioned on an LKB ultrotome V  (LKB 
Instruments, Inc., Gaithersburg, MD). Wet coverslips were transferred to Freon 
113 and dried after substitution with liquid CO2 in a  Polaron 3000 critical 
point dryer.  Dried coverslips were sputtered using a  gold-palladium (80:20) 
source in an E5100 Polaron sputtercoater (Polaron Instruments  Inc., Hatfietd, 
PA).  All samples were viewed  in an Hitachi H-600 STEM with a  LaB6 or 
pointed-W filament. 
Results 
Mabs 126 and 14.18 React Specifically with GD2 
on TLC 
To  demonstrate  anti-GD2  antibody-binding  specificity, we 
attempted to directly visualize the reactivity of Mabs 126 and 
14.18 on TLC plates that contained total glycolipid extracts 
from either M21  human melanoma  or various ganglioside 
standards. As shown in Fig.  IA, Mabs 126 and 14.18 reacted 
with authentic GD2 (lanes I and 2) as well as a co-migrating 
doublet from the M21 glycolipid extract (lanes 3 and 4). These 
Mabs did not react with any of the other known ganglioside 
standards,  i.e., GM2, GMI, or GD3. In addition, no reactivity 
was observed at the origin (arrow) of any of these lanes, which 
indicates the absence of reactivity with potential contaminat- 
ing glycoproteins in the glyeolipid preparation. The specificity 
of Mabs  126 and  14.18  for the GD2 ganglioside is further 
demonstrated by their inability to react with a glycoprotein 
extract  from  M21  cells.  As shown in Fig.  1  B,  these Mabs 
failed to react with a glycoprotein extract from these cells by 
Western immunoblot analysis (lanes 5  and 6). Mab 9.2.27, 
known to react with a glycoprotein antigen produced by these 
cells, reacted with a band of 250 kD (lane 7). 
GD2 Localization and Redistribution on the Surface 
of  M21 Human Melanoma Cells Is Associated with 
Cell Attachment to Fibronectin 
Surface localization of GD2 on fixed M21 human melanoma 
cells was assessed by indirect immunofluorescence with var- 
ious  Mabs  directed  to  the  oligosaccharide  portion  of this 
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(.4) Gangliosides purified from M21 human melanoma cells from a 
1 ~1 packed cell equivalent  (lanes 3 and 4) were separated by TLC 
along wih ---0.2 t~g of authentic GM2, GM~, GD3, and GD2 (lanes I 
and 2). Vis,alization of the standards  was achieved by either resor- 
cinol spray  (as depicted  on left) or by immunostaining with  Mab 
14.18 (lanes 1 and 3) or 126 (lanes 2 and 4). Arrow corresponds to 
the origin of  the TLC plate. (B) M21 human melanoma protein lysate 
was separated by SDS polyaerylamide eleetrophoresis, transferred to 
nitrocellulose paper, and stained by immunoblot analysis, using Mabs 
14.18 (lane 5), 126 (lane 6), and 9.2.27 (lane 7) as primary antibody 
as described in Materials  and Methods.  The position  of molecular 
weight standards (x 10  -3) appears to the right. 
ganglioside. As shown in Fig. 2, A-C, GD2 localized in di.~rete 
foei on the cell surface as well as on a  number of micropro- 
cesses,  which emanated from the main cell body when M21 
cells were attached and spread on a fibronectin substrate. In 
contrast, Mab 9.2.27, directed to a chondroitin sulfate proteo- 
glycan on  these  same  cells  (Fig.  2,  D-F),  localized  in  an 
extracellular  matrix  pattern  that  is above the  plane  of the 
substrate attachment domains of the cell. It is quite apparent 
that this proteoglycan antigen did not localize in the micro- 
processes that made contact with the substrate. 
To determine  whether any redistribution  of GD2 on the 
M21 cell membrane is associated with cell attachment, cells 
were allowed to attach and spread on a fibronectin substrate 
and subjected to fixation and indirect immunofluoreseence 
with or without prior exposure of anti--GD2 Mab for 1 h  at 
4"C. As shown in Fig. 3, A-C M21 cells that are stained with 
anti-GD2  after  attachment  for  various  times  and  not  pre- 
treated  with anti-GD2 attach and begin to spread at  5  min 
and at 20 rain are completely spread with a number of GD2- 
containing processes. In contrast, nonfixed viable cells treated 
with anti-GD2 for 1 h  at 4"C and then allowed to attach for 
5-20 rain (Fig. 3, D-F) show no spreading at 5-10 rain with 
minimal spreading at 20 rain. 
When spread cells are treated for I-2 min with EDTA to 
chelate divalent cations, the cells begin to round up as shown 
by SEM in Fig. 4A. Cells treated in this manner initially lose 
contact with the  substrate  leaving behind  focal attachment 
processes that stain positively for GD2 by indirect immuno- 
fluorescence (Fig. 4B). After complete cell removal (Fig. 4 C), 
Figure  2.  Immunolocalization of GD2 and 
ehondroitin  sulfate proteoglycan antigens on 
the surface of M21 human melanoma cells. 
M21 cells were allowed to attach to fibronec- 
fin-coated coverslips for 60 rain,  fixed, and 
stained by indirect immunofluorescence with 
Mab  126 (A-C) and Mab 9.2.27 (D-F) as 
described in Materials and Methods to visu- 
alize the surface expression of GD2 and the 
chondroitin sulfate core glycoprotein, respec- 
tively. The cells were photographed through 
a  Zeiss microscope  equipped  with  epiflu- 
orescence. Bar, 25 urn. 
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remain firmly associated with the fibronectin substrate.  The 
cells,  which ultimately are removed from the substrate with 
EDTA,  now  express  GD2  uniformly dispersed  around  the 
membrane as shown in Fig. 3A, which indicates that the focal 
distribution  of GD2 on  M21  cells is dependent  upon their 
attachment and spreading on a solid substrate. 
Detection of GD2 Preferentially Expressed on M21 
Cell Microprocesses Making Direct Contact with the 
Fibronectin Substrate 
Scanning immunoelectron microscopy demonstrates the pres- 
ence of GD2 on microprocesses involved in the attachment 
of M21  cells to a  fibronectin substrate.  As shown in Fig.  5, 
B-D, GD2 can be detected most heavily on microprocesses 
which project from the main cell body. The actual cell surface 
also expresses the antigen, however, at a much lower density. 
In contrast, Mab W6/32, which detects a common determi- 
nant of HLA histocompatibility class I antigens, is uniformly 
expressed on the M21 cell surface (Fig. 6, B and D), showing 
no particular preference for either cell body or microprocesses. 
Figure 3. Distribution change of  GD, surface 
expression  during  M21  cell attachment to 
fibronecfin.  M21  human  melanoma  cells 
were either preincubated at 4*(2 for I h in the 
presence of growth media (A-C) or the anti- 
GD2 Mab 14.18 (10 #g/ml) in growth media 
(D-F) and allowed to attach to fibronectin- 
coated covcrslips for either 5 (A and D),  10 
(B and E), or 20 rain (C and F). After fixa- 
tion, cells were stained by indirect immuno- 
fluorescence using Mab 14.18  to localize GD2 
on the cell surface as described in Materials 
and Methods.  The cells were photographed 
through a  Zeiss microscope  equipped  with 
epifluorescenee. Bar, 25 ~m. 
A  melanoma-associated  chondroitin  sulfate  protenglycan, 
identified  by Mab  9.2.27,  cannot be  detected  on adhesion 
processes of  M21 cells but rather appears on the apical surface 
of these cells in association with short bleblike structures on 
the plasma membrane (Fig. 6 C). 
In support  of the  above observations  TEM  also demon- 
strates that GD2 is localized directly on the microprocessess 
that make contact with the fibronectin substrate (Fig. 7, A- 
C).  As  shown  in  Fig.  7,  A  and  B  cross-sections  of these 
microprocesses are heavily labeled with colloidal gold as com- 
pared to the cell body as seen in Fig. 7A (upper fight). On a 
number of these cross-sections, GD2 can be localized directly 
at the points ofsubstrate contact (Fig. 7, B and C). In contrast, 
Mabs 9.2.27 primarily localizes to the apical surface of these 
cells when attached and fails to react with the microprocesses 
associated  with  the  basal  surface  of these  cells  (data  not 
shown). 
Ultrastructural Effects of  Anti-GD2 on M21 Cells 
Attached to Fibronectin 
SEM was used to analyze the ultrastructural effects of anti- 
GD2 on M21 cells. The cells were allowed to attach and spread 
Figure 4. Ultrastructural  and immunofluorescence  analysis of  M21 focal adhesion plaques. M21 human melanoma cells were allowed to attach 
to fibroncctin-coated  coverslips, treated with EDTA for 1 rain,  fixed, and examined by SEM (A) or indirect immunofluorescence  (B and C) 
using Mab 14.18 as described above. Arrows correspond to the focal adhesion plaque that remains on the fibronectin substrate. 
The Journal of  Cell Biology,  Volume 102, 1986  1890 Cheresh and Klier GD2 in Melanoma Cell Attachment  1891 Figure 5. Immunolocalization  of  GD2 on M21 microprocesses  by scanning immunoelectron microscopy.  M21 cells were allowed to attach and 
spread on fibronectin-coated  coverslips, fixed with 0.5% glutaraldehyde, and stained using either irrelevant Mab KS 1/4 (.4) or anti-GD2 Mabs 
126 (B), 3F8 (C), and 14.18 (D) as primary antibodies followed  by anti-mouse  conjugated  to colloidal  gold (20-30 nm) as described in Materials 
and Methods. 
on a  fibronectin substrate and then overlayed with purified 
anti-GD2  for 3-4 h. Most (90%) became rounded in appear- 
ance, whereas controls overlayed with Mab 9.2.27  or a non- 
binding irrelevant Mab revealed  no perturbation of the cell 
monolayer. Control cells, when washed,  fLXed, and analyzed 
by SEM remained firmly attached and spread with multiple 
attachment points which involved many microprocesses that 
made direct contact with the cell surface (Fig. 8A). In contrast, 
M21 cells ovcrlayed  with anti-GD2 not only caused cell round- 
ing  but  also  detachment  of the  microprocesses  from  the 
fibronectin substrate  (Fig. 8 B), again suggesting that the spe- 
cific localization of  GD2 in these structures on the melanoma 
The Journal of Cell Biology,  Volume 102, 1986  1892 Figure 6.  Immunolocalization of a chondroitin sulfate proteoglycan and class I histoeompatibility antigen by scanning immunoelectron 
microscopy. M21 cells were treated identically as in Fig. 5, however, the primary Mabs were changed, i.e., (C) Mab 9.2.27 and (B and/9) Mab 
W6/32. 
Cheresh and Klier  G  D2 in Melanoma Cell Attachment  1893 Figure 7. TEM immunolocalization of GD2 on M21 microprocesses and cell-fibronectin contact points. M21 cells were allowed to attach to 
fibronectin-coated coverslips and stained with Mab 14.18 and (7-9 nm) gold-labeled anti-mouse Ig and prepared for TEM as described in 
Materials and Methods. Arrows correspond to substrate. (,4) Includes a cross-section of the cell body (upper fight) as well as microprocesses. 
(B) Demonstrates cross-sections  of microprocesses that make direct contact with the substrate. (C) Demonstrates a longitudinal section of two 
microprocesses  that make direct contact with the substrate. 
cell surface are directly involved in cell-fibronectin interac- 
tions. 
Discussion 
A novel approach to study the functional properties of gan- 
gliosides is facilitated by antibodies that bind to the carbohy. 
drate portion of the molecule when naturally exposed on the 
cell  surface.  In  the  present  paper,  we  used  specific Mabs 
directed to GD2, the major ganglioside on M21  human mel- 
anoma cells, to demonstrate that this molecule plays a signif- 
icant role in M21  cell attachment and spreading on a fibro- 
nectin substrate. 
The production of  highly specific Mabs directed to a variety 
of ganglioside antigens (3,  7-9,  12,  20,  25,  30,  37,  38) has 
aided considerably in  the  identification  of new ganglioside 
structures  previously unidentified  and  has been  helpful  in 
determining the specific tissue localization of certain ganglio- 
sides (6,  9,  17,  34,  38).  We previously characterized several 
Mabs directed to gangliosides present on the surface of  human 
tumors of neuroectodermai origin (6,  7-9,  38).  Using Mabs 
directed specifically to gangliosides GD3 and GD2 we could 
localize these molecules on the surface of human melanoma 
cells and in their focal adhesion plaques after their attachment 
to glass coverslips (8).  We also demonstrated that  pretreat- 
merit of  human melanoma cells with either anti-GD2 or anti- 
GD3 Mabs inhibited their ability to attach to  a  number of 
extracellular matrix proteins (10).  These data are in support 
of the studies that implicate gangliosides in cell-substratum 
interactions  (18,  29,  49).  The  conclusion  reached  in  these 
reports were based upon the exogenous addition of ganglio- 
sides to cultured cells under the assumption that the exoge- 
nously added gangliosides could embed appropriately in the 
plasma membrane of the cells being examined. 
In this paper, we provide direct evidence that gangliosides 
are molecules involved in M21 human melanoma cell attach- 
ment to the extracellular matrix. In this regard, we demon- 
strated by immunolocalization with anti--GD2 Mabs that GD2 
rapidly distributes into cell attachment domains of M21  hu- 
man melanoma cells almost immediately after their attach- 
ment  and  spreading  on  a  fibronectin  substrate.  GD2  was 
shown  to  preferentially localize within  microprocesses that 
extend from the cell body and make direct contact with the 
fibronectin substrate. This was clearly indicated both by in- 
direct  immunofluorescence  and  scanning  immunoelectron 
microscopy. Although the experiments in this study included 
an examination of  GD~ on M21 cells after 60 rain of  adhesion, 
we observed a similar distribution of this antigen after 24 h 
of adhesion (data not shown). The preferential distribution of 
GD2 was demonstrated by the lack of redistribution of two 
other M21 cell surface antigens. Thus, identical treatment of 
M21  cells  with Mab 9.2.27,  which  identifies a  chondroitin 
sulfate proteoglycan core glycoprotein, localized this antigen 
primarily on the apical surface of these cells,  whereas Mab 
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uniformly over their entire surface rather than localized pref- 
erentially on microprocesses. 
The use of anti-GD2 Mabs also facilitated monitoring of 
the redistribution of GD2 on these cells during morphological 
changes associated with their rapid attachment and spreading 
on a  fibronectin substrate.  Specifically, GD2 was shown to 
redistribute  from a  focal to  a  uniform pattern  during  cell 
rounding  induced  by  chelation  of  divalent  cations  with 
EDTA.  Moreover, M21  cells undergoing mitosis lose their 
spread appearance while simultaneously demonstrating a uni- 
form GD2 expression (data not shown).  Additionally, treat- 
ment of fibronectin-attached M21  cells with anti-GD2 Mabs 
resulted in a similar cell rounding and detachment of the cell 
membrane-associated  microprocesses  from  the  substrate. 
Collectively, these data implicate GD2 on M21  human mel- 
anoma cells as playing a direct role in their ability to attach 
and spread on fibronectin. 
The M21 cell line was used as a model in these studies for 
two reasons. First, this cell line shows very rapid binding to 
immobilized fibronectin since in 30 rain >75%  of the cells 
are  attached  (10).  Second,  M21  cells contain  GD2  as their 
major ganglioside (>60% of the total), thus allowing the use 
of two available anti-GD2 Mabs of different isotype to probe 
the  system.  Moreover,  we  demonstrate  that  the  anti-GD2 
Mabs used in this study recognize the oligosaccharide on a 
lipid backbone only, since these reagents could not recognize 
Figure  8.  Detachment  of M21  cells from 
fibronectin substrate by anfi-GD2  Mab. M21 
cells were allowed to attach and spread on a 
fibronectin-coated coverslip for 1 h at 37"C. 
The  cells were overlayed with 100  #g/ml 
irrelevant Mab (.4) or Mab 14.18 (B) for 3 h 
at 37"C. The cells were fixed and prepared 
for SEM as described in Materials and Meth- 
otis. Arrows correspond to attachment-pro- 
moting rnicroprocesses. 
a determinant by Western blot analysis (Fig.  1). It is tempting 
to speculate that a variety of gangliosides on other cell types 
may indeed have similar properties as GD2 on M21  cells. In 
fact, Mabs directed to the GD3 ganglioside inhibited M21 cell 
attachment  ot  fibronectin  (10),  however,  significantly  less 
than that observed with anti-GD2 Mabs, which suggests that 
either ganglioside can serve a similar role in cell attachment 
depending on its relative surface expression. Moreover, Okada 
et al. demonstrated by biochemical means that GM3, a major 
ganglioside on the surface of baby hamster kidney cells, can 
be localized on their detergent-insoluble substrate attachment 
matrix  (26).  In  another  study (24),  it  was  found  that  the 
substrate-attached  material  from  either  normal  or  virally 
transformed  BALB/c  3T3  cells  was  relatively rich  in  the 
disialoganglioside GDla. These findings are consistent with 
our previous results (10),  which indicate that the substrate- 
attached gangliosides do not represent indiscriminant mem- 
brane fragments. 
A  more direct interaction between gangliosides and fibro- 
nectin was indicated by Spiegel et al. who showed that exog- 
enous addition of flourescence-labeled, complex gangliosides 
to transformed mouse fibroblasts caused retention of fibro- 
nectin into fibrillar networks on the cell surface (41,  42).  A 
number of reports have indicated that the exogenous addition 
of polysialogangliosides to  fibronectin-attached cells  caused 
them to round up and detach from the substrate (18, 29, 49). 
These studies led to the conclusion that gangliosides may act 
Cheresh and Klier GD~ in Melanoma  CelI Attachment  1895 as  specific  fibronectin  receptors.  However,  this conclusion 
may  now  be  doubtful  because  of more  recent  reports  of 
specific membrane-associated glycoprotein receptors for fibro- 
nectin (31), vitronectin (32), and laminin (33). Alternatively, 
these data suggest that gangliosides may augment cell attach- 
ment and spreading by acting synergistically with such cell 
surface receptors.  In this case, depending on the oligosaccha- 
ride  moiety,  individual  gangliosides  may  redistribute  into 
discrete cell attachment domains, thereby creating an appro- 
pilate  electrostatic  environment for  optimal  cell  adhesion. 
Our data are consistent with either hypothesis since we can 
preferentially  localize the GD2 gangliosides in cell attachment 
domains on human melanoma cells that contain this ganglio- 
side. 
The fact that GD2 contains two sialic acid moieties, thus 
carrying two negative charges,  argues against the possibility 
that the distribution we observed is due to random mobility 
of this molecule in the membrane of M21  cells, since such 
highly charged molecules  in the membrane  would tend to 
repel  one another. However,  it is conceivable that divalent 
cations, known to be required for fibronectin-mediated cell 
attachment (5, 27), are involved in a complex that contains 
the negatively charged ganglioside on the cell surface, thereby 
allowing them to distribute preferentially  into certain domains 
on the cell surface. This contention is consistent with the data 
reported by Sharom and Grant who demonstrated that phys- 
iological levels of Ca  +2 and Mg  +2 lead to cross-linking and 
condensing of ganglioside headgroups in membranes by com- 
plexing carboxyl residues of sialic acid (39). Therefore, in the 
presence of divalent cations, it is possible that laterally mobile 
carbohydrate-beating components such as gangliosides may 
show a tendency to cluster about complex glycoproteins that 
contain one or several carboxyl groups. This hypothesis may 
help to explain the numerous reports that implicate gangho- 
sides and other glycoconjugates in the cell attachment process 
despite the recent convincing data that demonstrate the pres- 
ence of specific cell surface protein receptors for components 
of the extracellular matrix. 
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